GV was among the investors in a round that valued the big data-infused health insurance company, which has now raised $425m inside two years, at $1.2bn.

Novo Seeds and Lundbeckfonden Emerge took part in a $17.7m Sofinnova Ventures-led round that will advance Dermtreat's mucosal disease treatment patch to phase 2 tests.

SoftBank has led a round that took the liquid biopsy system developer's total funding to about $550m, as part of a joint venture agreement between the companies.

The investment included secondary purchases from existing investors, the electronic health record system developer having previously been backed by Pentland and IBM.

Horizon Pharma has agreed to pay $145m upfront to buy River Vision Development Corp, enabling GlaxoSmithKline and Lundbeck to exit.

Fertility benefits platform developer Progyny has raised $10m from investors including SR One to increase its series B round to $24.7m.